NASDAQ:LVTX
Delisted

Lava Therapeutics B.v Stock Predictions

etoro logo Buy LVTX
*Your capital is at risk
$1.74
+0 (+0%)
At Close: Feb 27, 2026
Currently predicting for Fri, 5 Jun 2026

LVTX Prediction Chart

LVTX Predictions History

Latest community submissions for LVTX.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Jan 31, 2024 $1.68 -2.89% $1.67 V 99.40% 4
Jan 31, 2024 $1.80 +3.79% $1.67 X 92.48% 0
Jan 31, 2024 $1.69 -2.37% $1.67 V 98.86% 2
BullishBunny89 BullishBunny89 Amateur
Aug 9, 2023 Bullish $1.80 V 1
JS JS Pro
Jul 10, 2023 $1.96 +1.55% $1.92 X 97.92% 0
Jul 10, 2023 $2.00 +3.45% $1.92 X 96.02% 0
Jul 10, 2023 $1.97 +2.15% $1.92 X 97.31% 0
BullishBunny89 BullishBunny89 Amateur
Jul 10, 2023 Bullish $1.92 X 0
Jun 27, 2023 $2.04 -4.24% $2.07 V 98.54% 2
Jun 27, 2023 $2.07 -2.65% $2.07 V 99.83% 6
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LVTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT LAVA THERAPEUTICS B.V.
Lava Therapeutics B.V
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-051, which is in Phase 1/2a clinical trial for b...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE